Please login (Members) to view content or
(Nonmembers) this article.
No votes yet

Current Clinical Issues in Systemic Therapy for Metastatic Breast Cancer

Frances M. Palmieri
Debra K. Frye
Suzanne M. Mahon
CJON 2009, 13(1), 4-10 DOI: 10.1188/09.CJON.S1.4-10

The selection of therapy for women with metastatic breast cancer requires consideration of many factors. Multiple treatment options are available, including hormonal therapy, chemotherapy, and biologic therapy. Many issues exist regarding choice of agent(s), combination therapies, sequencing, and duration of therapy. Oncology nurses must understand the rationale behind the approaches so they can effectively administer the agents and monitor for side effects. Such knowledge enhances treatment-option counseling for patients, thus promoting a sense of well-being for patients with breast cancer. This article reviews strategies for the initial treatment of metastatic breast cancer and for later lines of treatment when resistance develops. It also provides nursing perspective on clinical factors that arise during the course of treatment.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or